🇺🇸 FDA
Patent

US 11026978

Compositions and methods for treating multiple sclerosis and related disorders

granted A61KA61K35/38A61K9/0053

Quick answer

US patent 11026978 (Compositions and methods for treating multiple sclerosis and related disorders) held by Finch Therapeutics Holdings LLC expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Finch Therapeutics Holdings LLC
Grant date
Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K35/38, A61K9/0053, A61P, A61P25/28